Search by Drug Name or NDC

    NDC 71336-1001-01 GIVLAARI 189 mg/mL Details

    GIVLAARI 189 mg/mL

    GIVLAARI is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alnylam Pharmaceuticals, Inc.. The primary component is GIVOSIRAN SODIUM.

    Product Information

    NDC 71336-1001
    Product ID 71336-1001_c47a10ee-f647-4319-85e9-8b7505637bde
    Associated GPIs 85080025202020
    GCN Sequence Number 080500
    GCN Sequence Number Description givosiran sodium VIAL 189 MG/ML SUBCUT
    HIC3 D7K
    HIC3 Description DRUGS TO TREAT ACUTE HEPATIC PORPHYRIA (AHP)
    GCN 47364
    HICL Sequence Number 046222
    HICL Sequence Number Description GIVOSIRAN SODIUM
    Brand/Generic Brand
    Proprietary Name GIVLAARI
    Proprietary Name Suffix n/a
    Non-Proprietary Name givosiran sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 189
    Active Ingredient Units mg/mL
    Substance Name GIVOSIRAN SODIUM
    Labeler Name Alnylam Pharmaceuticals, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212194
    Listing Certified Through 2024-12-31

    Package

    NDC 71336-1001-01 (71336100101)

    NDC Package Code 71336-1001-1
    Billing NDC 71336100101
    Package 1 VIAL, SINGLE-USE in 1 CARTON (71336-1001-1) / 1 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2019-12-12
    NDC Exclude Flag N
    Pricing Information N/A